Carl Zeiss Meditec strengthens business in Turkish growth market
Long-standing partner Optronik AS acquired
With direct market access, ZEISS is looking to tap even more effectively into the potential of the fast-growing Turkish market. "The sustained upward trend in the Turkish market has convinced us to put our partnership with Optronik on a new footing following a positive working relationship of many years' standing, and to set the course for further growth under the ZEISS umbrella by acquiring all shares in the company as of the end of 2013," says Dr. Ludwin Monz, President and CEO of Carl Zeiss Meditec AG.
The former partner's knowledge of the market and excellent client contacts will continue to be utilized within the new structure. All employees will be retained, and the company's head office will remain in Ankara, Turkey. The present Managing Director will also contribute to a smooth transition to the new structure by remaining as a consultant for ZEISS.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.